Quercis Pharma
Quercis
- Employees
- 1–10
- Business Model
- B2B
- Website
- quercis.com
- Total Funding
- $150.0M
- Last Round
- $150.0M Growth EquityDec 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Quercis Pharma is a late clinical-stage biotech developing investigational therapies for urgent medical challenges, with the goal of bringing safe, effective, and affordable medicines to patients. Its homepage mission is healing without harm, and its highlights page describes Phase III assets with intellectual property extending through 2045. The pipeline includes a Phase 3 program for cancer-associated thrombosis under an FDA Special Protocol Agreement, plus work in sickle cell disease, ALS, COPD, and viral diseases.
Summary
Quercis Pharma is a Biotech company. It has raised $150.0M in total across 1 round, most recently a $150.0M Growth Equity round in Dec 2021.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2021
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/quercis-pharma"><img src="https://indexed.vc/api/badge/company/quercis-pharma" alt="Quercis Pharma on Indexed.vc" width="260" height="76" /></a>